A comparative study on idiopathic pulmonary fibrosis and secondary diffuse parenchymal lung disease

Indian Journal of Medical Sciences

Volumn 58, Issue 5, 2004, Pages 185-190

  Subhash, H S ^a,b   Ashwin, I ^a   Solomon, S K ^a   David, T ^a   Cherian, A M ^a   Thomas, K ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b REPATRIATION GENERAL HOSPITAL   (Australia)

Author keywords

Azathioprine; Collagen vascular disease; Cryptogenic pulmonary fibrosis; Idiopathic pulmonary fibrosis; Prednisone

Indexed keywords

AZATHIOPRINE; PREDNISONE;

ADULT; AGE DISTRIBUTION; ARTICLE; CHI SQUARE DISTRIBUTION; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; COUGHING; DIFFUSE PARENCHYMAL LUNG DISEASE; DYSPNEA; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; LUNG DISEASE; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SARCOIDOSIS; SYMPTOM; TREATMENT OUTCOME;

DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; PULMONARY FIBROSIS;

EID: 3042854529     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Jindal SK, Gupta D. Incidence and recognition of interstitial pulmonary fibrosis in developing countries. Current opinion in pulmonary medicine 1997;3:378-83.
2. Sharma SK, Panda JN, Guleria JS. Diffuse interstitial pulmonary fibrosis. Indian J Chest Dis All Sci 1984;26:214-9.
3. Jindal SK, Malik SK, Deodhar SD, Sharma BK. Fibrosing alveolitis: a report of 61 cases seen over the past five years. Indian J Chest Dis All Sci 1979;21:174-9.
4. Gupta D, Behera D, Joshi K, Jindal SK. Role of fiberoptic bronchoscopy (transbronchial lung biopsy) in diagnosis of parenchymatous lung disease. J Assoc Physicians India 1997;45: 371-3.
5. Thiruvengadam KV, Chandrasekaran AN, Kulandaivelu V, Inbavazhvu MN, Venkatramani K. Pleuro pulmonary manifestation of rheumatoid arthritis. Indian J Chest Dis All Sci 1979;21: 35-52.
6. Behera D, Gupta D, Jindal SK. Response to steroid therapy in patients of Idiopathic pulmonary Fibrosis : A retrospective analysis. Indian J Chest Dis All Sci 1998;40:163-9.
7. Mahajan R, Daga MK, Tiwari N. Diffuse parenchymal lung disease: an approach to diagnosis J Assoc Physicians India 2002;50: 1285-94.
8. Ryu JH, Colby TV, Hertman TE. Idiopathic pulmonary fibrosis: current concept. Mayo Clin Proc 1998;73:1085-101.
9. American Thoracic Society/European Respiratory Society. International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
10. Kennedy JI, Fulmer JD. Pulmonary hypertension in the interstitial lung disease. Chest 1985;87: 558-9.
11. Erbs R, Schaberg T, Loddenkemper R. Lung function tests in patients with idiopathic pulmonary fibrosis. Are they helpful in predicting outcome? Chest 1997;111:51-7.
12. Reynolds HY. Diagnosis and management strategies for diffuse interstitial lung disease. Chest 1998;113:192-202.
13. Richeldi L, Davies HR, Ferrara G, Franco F. Corticosteroids for idiopathic pulmonary fibrosis. Cochrane Database Syst Rev 2003;3: CD002880.
14. Davies HR, Richeldi L. Idiopathic pulmonary fibrosis current and future treatment options. Am J Med 2002;1:211-24.
15. Raghu G, Depaso WJ, Cain K, Hammar SP, Wetzel CE, Dreis DF, et al. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. Am Rev Respir Dis 1991;144:291-6.
16. Davies HR, Richeldi L, Walters EH. Immunomodulatory agents for idiopathic pulmonary fibrosis. Cochrane Database Syst Rev 2003;3:CD003134.
17. Al - Mobeireek. Management of interstitial lung disease: an audit at a university teaching hospital in Saudi Arabia. Indian J Chest Dis All Sci 1998; 40:235-41.
18. Agusti C, Xaubet A, Roca J, Agusti AGN, Rodriguez-Roisin. Interstitial pulmonary fibrosis with and without associated collagen vascular disease: result of a two year follow up. Thorax 1992;47:1035-40.